Nov 07, 2012

Previous research has shown that fatigue is an under­estimated cause of underperformance among physicians. The issue of production pressure and its effect on quality of care permeates every aspect of...

Oct 26, 2012

The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease. An estimated 5,430...

Oct 25, 2012

A study conducted on mice has found that fluorescence-guided surgery (FGS) appears to lead to better outcomes for resecting pancreatic cancer than bright light surgery (BLS). FGS also was associated w...

Oct 22, 2012

Heavy concentrations of secondhand smoke, such as those found in smoke-filled bars and cars, can lead to airway restriction for bystanders within minutes of exposure. The study, presented at CHEST 201...

Oct 16, 2012

A study presented at the Anesthesiology 2012 annual meeting found that during the years 2000-2009, eye injuries during robotic-assisted radical prostatectomy (RARP) increased nearly 10-fold, from a .0...

Oct 12, 2012

Celgene Corporation today announced the U.S. Food and Drug Administration (FDA) has approved Abraxane (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) for the first-line ...

Oct 11, 2012

A cohort study of patients with advanced cancer and their informal caregivers has found that five factors appear to be associated with the highest quality of life (QOL) at the end of life: 1. Avoidanc...

Oct 10, 2012

Nearly half of all patients with metastatic cancer have incurable disease, but these individuals can live for years after their initial diagnosis. Palliative care can be used during this period to imp...

Oct 04, 2012

University of North Carolina researchers have found that decision-making patterns appear to vary among patients with localized prostate cancer. Patient-only decision making (vs physician-only) was mor...

Oct 04, 2012

For patients with ovarian cancer, social attachment appears to be associated with a survival advantage. A team of American researchers found that 59% of ovarian cancer patients with high social attach...

Oct 01, 2012

In 2012, the United States Preventive Services Task Force (USPSTF) updated screening recommendations for cervical cancer. According to the update, an annual Pap smear is not necessary to prevent death...

Sep 27, 2012

Priority review completed one month ahead of goal date The U.S. Food and Drug Administration today approved Stivarga (regorafenib) to treat patients with colorectal cancer that has progressed after...

Sep 25, 2012

Previous research suggests that timely delivery of appropriate healthcare services may prevent almost half of all pregnancy-related deaths in the United States. Although maternal deaths are increasing...

Sep 20, 2012

For patients with benign intracranial meningio­mas, single-fraction stereotactic radiosurgery appears to provide a high rate of tumor control. A ret­rospective review of 416 patients who underwent t...

Sep 18, 2012

The U.S. Food and Drug Administration today approved the first ultrasound device for use in combination with a standard mammography in women with dense breast tissue who have a negative mammogram and ...

Sep 12, 2012

The U.S. Food and Drug Administration today approved the production and use of Choline C 11 Injection, a Positron Emission Tomography (PET) imaging agent used to help detect recurrent prostate cancer....

Sep 06, 2012

A team of investigators has found that pain intensity appears to be highly variable in patients with stage IV cancer. High pain variability was most likely to occur among the following: Minorities. ...

Sep 04, 2012

The U.S. Food and Drug Administration today approved Bosulif (bosutinib) to treat chronic myelogenous leukemia (CML), a blood and bone marrow disease that usually affects older adults. An estimated...

Aug 31, 2012

The U.S. Food and Drug Administration today approved Xtandi (enzalutamide) to treat men with late-stage (metastatic) castration-resistant prostate cancer that has spread or recurred, even with medical...

Aug 30, 2012

The utility of distress screening appears to vary among cancer clinicians, according to findings from a British investigation. Researchers found that clinicians believed screening was useful in 43% of...